<DOC>
	<DOCNO>NCT01778010</DOCNO>
	<brief_summary>Treatment cocaine dependence characterize high rate relapse , yet factor influence likelihood relapse poorly understood . Exposure cocaine , stress cocaine-related cue increase cocaine craving , genetic polymorphism dopamine D4 receptor subtype ( DRD4 ) influence effect cue drug exposure rating crave . However , crave robustly predict drug use relapse . There currently data characterize interaction DRD4 polymorphism , cue cocaine exposure actual cocaine taking , i.e. , cocaine self-administration . Incorporating measure relapse establish laboratory model important objective medication development model cocaine self-administration predictive validity screen medication cocaine dependence . Aim 1 : Refine cocaine self-administration procedure include measure relapse . The model guide hypothesis support pilot data : The likelihood relapse quantity cocaine self-administered follow relapse vary function ( 1 ) cost cocaine , ( 2 ) presence contextual cue associate cocaine-taking , ( 3 ) noncontingent cocaine administration ( i.e. , 'priming ' ) . Aim 2 : Determine influence DRD4 polymorphisms cue- cocaine-induced relapse . Data alcohol demonstrate individual heterozygous homozygous 7 allele repeat ( DRD4L ) show increase cue- alcohol-induced craving great relapse clinically few 7 allele repeat ( DRD4 S ) . We hypothesize cocaine-dependent DRD4 L volunteer show great cue- prime-induced relapse compare DRD4 S group . Aim 3 : Test effect modafinil measure cocaine relapse function DRD4 polymorphism . We hypothesize modafinil : ( 1 ) decrease effect cue cocaine prime likelihood relapse compare placebo , ( 2 ) decrease amount cocaine self-administered cocaine use initiate , ( 3 ) effective decrease cue-and cocaine-induced relapse DRD4 L group DRD4 S group . This study provide valuable information interaction genetic variability , modafinil environmental factor believe increase cocaine relapse .</brief_summary>
	<brief_title>Modafinil , DRD4 Genotype Cocaine Relapse</brief_title>
	<detailed_description>Provide extensive description , desire . I desire .</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>1 . Smokes cocaine 2 . Has pattern smoke cocaine use term frequency amount parallel exceed administer study . 3 . Age 2150 . 4 . Able give inform consent , comply study procedure . 5 . Normal body weight Within normal weight range ( appropriate frame ) accord 1983 Metropolitan Weight table 1 . Current seizure disorder , heart disease history serious adverse effect due cocaine . 2 . Dependence substance ( cocaine nicotine ) history dependence alcohol 3 . Request drug treatment 4 . Judged noncompliant study protocol . 5 . Current use psychotropic medication . 6 . Clinical laboratory test outside normal limit clinically unacceptable study physician ( BP &gt; 140/90 ; BUN , creatinine , LFTs &gt; 3x ULN ; hematocrit &lt; 34 woman , &lt; 36 men ; pseudocholinesterase deficiency ) 7 . History myocardial infarction ischemia , clinically significant leave ventricular hypertrophy , angina , clinically significant arrhythmia , mitral valve prolapse 8 . Currently meet DSMIV criterion major psychiatric/psychotic disorder transient psychosis due drug abuse 9 . Current parole probation Selfreport interview</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>cocaine</keyword>
	<keyword>modafinil</keyword>
	<keyword>self-administration</keyword>
	<keyword>DRD4</keyword>
</DOC>